106 results
Page 3 of 6
6-K
EX-99.3
10mfdruycyeiyf35
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.4
g3tn avzbkdq54z2
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
gkz 3836cjgscz
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
nr5bcyj4 60dq1woa
11 Jul 22
Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
4:05pm
6-K
EX-99.1
tj7pilvf
27 Jun 22
Current report (foreign)
4:05pm
6-K
EX-99.1
007i acg6mdyrqho2
8 Jun 22
KIMMTRAK is the first and only treatment approved in the UK, Australia, and Canada to treat patients with unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
veey25th2b
6 Jun 22
Immunocore presents new data on KIMMTRAK (tebentafusp-tebn) in metastatic
4:21pm
6-K
EX-99.1
irt5f
3 Jun 22
Sanofi will evaluate KIMMTRAK in combination with SAR444245 as part of its ongoing Phase 1 study in advanced unresectable or metastatic skin cancers
4:05pm
6-K
EX-99.3
chm47n34u dzd1pih4tw
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
424B7
9293ll5
5 May 22
Prospectus with selling stockholder info
12:00am
F-3ASR
EX-4.4
zznx556rl3qrhcv
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
F-3ASR
EX-4.6
ox368emlvas 47nrks
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
F-3ASR
8stk6sw5fevjmrgm5
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
F-3ASR
EX-4.7
epe2xhni c8up3pft48
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
6-K
EX-99.1
392jq 80f7ighwz8
4 Apr 22
European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
5mayvc5wh3xke
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
e6nsf
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
v07x9ll9kjo28l
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
lf8vty 51bs
24 Aug 21
Current report (foreign)
4:33pm